Sucrobind Tablet: Effective Digestive Aid for Stable Blood Sugar Levels

Sucrobind Tablet

Description:

• Contains the active component sucroferric oxyhydroxide.
• Classified as a phosphate binder.
• Treats hyperphosphatemia in patients with chronic kidney disease (CKD) who are on dialysis.
• Contains iron, which can benefit individuals with CKD who often experience iron deficiency anemia.

Uses:

• Treatment of high phosphate levels in the blood.

Therapeutic Effects:

• Lowers elevated phosphate levels in the blood by binding to dietary phosphate in the gastrointestinal tract.
• Prevents absorption of phosphate into the bloodstream, thereby reducing the overall phosphate burden.
• Helps manage hyperphosphatemia and minimize associated risks such as bone disease and cardiovascular complications.

Interaction with Other Drugs:

• Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Sucrobind Tablet, reducing effectiveness or causing undesirable side effects.

Storage:

• Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

How to Consume:

• Follow the instructions provided by your healthcare professional or the guidelines on the medication packaging.
• Typically taken orally as chewable tablets with meals or shortly after eating.
• Dosage and frequency of administration will depend on your specific medical condition and individual needs.
• Chew the tablets thoroughly before swallowing.
• Consult your healthcare provider for alternative administration options if you have difficulty chewing.

Safety Advices:

• Pregnancy: Caution is advised when considering the use of this medication during pregnancy.
• Breastfeeding: Caution is advised when considering the use of this medication during breastfeeding.
• Lungs: Sucrobind Tablet is not known to have specific safety concerns related to the lungs.
• Liver: The safety of Sucrobind Tablet in individuals with liver disease has not been extensively studied.
• Alcohol: Excessive alcohol consumption can negatively affect your health, especially if you have underlying liver disease or other medical conditions.
• Driving: Sucrobind Tablets can cause side effects that may impair your ability to drive or operate machinery safely.

Side Effects:

• Serious: allergic reaction, breathlessness, black stools.
• Common: diarrhea, discolored feces (usually dark or black), constipation, nausea, vomiting, stomach pain or discomfort, indigestion or heartburn.

Word of Advice:

• Allergic reactions are rare but require immediate medical attention if they occur.
• Regular monitoring of iron levels is necessary due to the iron content of the medication.
• Caution should be exercised in individuals with gastrointestinal disorders.
• Regular communication with healthcare providers is essential to address concerns and promptly report any concerning symptoms or side effects.

FAQs:

1. Can Sucrobind Tablet cause interactions with certain laboratory tests or diagnostic procedures?

   • Sucrobind tablets may interfere with certain laboratory tests that measure iron or phosphate levels. Inform healthcare professionals performing these tests that you are taking this medication.

2. Can Sucrobind Tablet be used in patients with kidney dysfunction?

   • Sucrobind Tablet is primarily used in patients with chronic kidney disease who are on dialysis. In patients with severe kidney dysfunction who are not on dialysis, the use of this medication may need to be carefully evaluated by a healthcare provider.

3. Can Sucrobind Tablet be used in patients with a history of gastrointestinal bleeding or ulcers?

   • The use of Sucrobind Tablet in patients with a history of gastrointestinal bleeding or ulcers should be cautiously approached. Discuss your medical history with your healthcare provider.

4. Can Sucrobind Tablet be used in elderly patients?

   • Sucrobind Tablets can be used in elderly patients; however, caution should be exercised due to the increased likelihood of age-related conditions and potential interactions with other medications.

5. Can Sucrobind Tablet be used long-term?

   • Sucrobind Tablet is often used as a long-term treatment for chronic kidney disease in patients on dialysis. The duration of treatment is determined by your healthcare provider based on your individual needs and response to therapy.

6. What should I do if I experience side effects while taking Sucrobind Tablet?

   • Report any side effects to your healthcare provider promptly. They can evaluate the symptoms and determine the appropriate course of action.

Fact Box:

• Molecule name: Sucroferric oxyhydroxide.
• Therapeutic class: Phosphate lowering agent.
• Pharmacological class: Phosphate binders.
• Indications: High Phosphate Levels in Blood.

टैग्स: diabetes, medication, sucralfate, tablets, healthcare, medicalsupply, drug, treatment, medicine, healthproduct